The first non-invasive

Pre-Implantable

Cardiac Monitor

Nuubo is the first textile with integrated electrodes capable to record 2 ECG leads continuously for up to 30 days. Increase your patient’s satisfaction and compliance. Have more data to base your decisions on. Palpitations, Syncope, Cryptogenic Stroke are clinical indications where 30-day monitoring is recommended.

The Technology

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

The Technology

2 Min

In this video we would like to introduce you the benefits of Nuubo.

The Product

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

How it works

2 Min

In this video we would like to explain how our product works.

Proven Clinical Benefits

Yield of atrial fibrillation detectionwith TextileWearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry

Jorge Pagola h, Jesus Juega h, Jaume Francisco-Pascual i, Angel Moya i, Mireia Sanchis h, Alejandro Bustamante j, Anna Penalba j, Maria Usero k, Elisa Cortijo k, Juan F. Arenillas k, Ana I. Calleja k, Maria Sandin-Fuentes l, Jeronimo Rubio l, Fernando Mancha m, Irene Escudero-Martinez m, Francisco Moniche m, Reyes de Torres m, Sara Eichau m, Carlos E. González-Matos m, Ángela Vega m, Alonso A. Pedrote n, Eduardo Arana-Rueda n, Joan Montaner j,m, Carlos A. Molina h, Marian Muchada h, David Rodriguez-Luna h, Noelia Rodriguez h, Estela Sanjuan h, Marta Rubiera h, Sandra Boned h, Marc Ribóh, Estefania Montiel h, Jose Beato-Coelho h, Teresa González Alujas o, Arturo Evangelista o

Patient's Compliance

146 out of 154 completed the prescribed 28-days monitoring. Only 8 patients did not complete the monitoring due to discomfort with the vest.

DIAGNOSTIC YIELD

The diagnostic yield was 3 times higher with Nuubo. Longer monitoring time has higher a diagnostic yield. 

Market Opportunity

12 M Holter test / year only in UE and USA.

HIGHLY PREVALENT

33 million

Have arrhythmia, incidence increases with age and risk factors Atrial Fibrillation is the most common arrhythmia

 

AFIB

40%

Lifetime risk of Atrial Fibrillation for individuals over age 55

STROKE

5x

Increased risk of stroke due to Atrial Fibrillation

HUGE PERSONAL COST

390.000

Deaths/year due to AF

Become part of our

sales team

Lead the change. We are looking for partners to introduce Nuubo to the world. 

Log in

Please enter your ID

Ileana HockingIleana
Ken BullockKen
The Heart Beat Clinicheartbeat
Estudio CohorteCOHORTE
ProsmedicaProsmedica
Demo Salesdemosales
Demo Customerdemocustomer
Newtech ItaliaNewtech
Medsafe LatamMedsafe
Novamedical PortugalNovamedical
cudbein Brazilcudbein
UKB Registryukb

Using.nuubo.com is propriety of Nuubo.  

www.nuubo.com